Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001543256-20-000001
Filing Date
2020-02-26
Accepted
2020-02-26 11:58:20
Documents
1
Effectiveness Date
2020-02-26
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8568
  Complete submission text file 0001543256-20-000001.txt   9677
Mailing Address ATTN: WILLIAM HEARL, 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD 20850
Business Address ATTN: WILLIAM HEARL, 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD 20850 301-728-0860
Immunomic Therapeutics, Inc. (Filer) CIK: 0001543256 (see all company filings)

EIN.: 203878827 | State of Incorp.: DE | Fiscal Year End: 1212
Type: D | Act: 33 | File No.: 021-361369 | Film No.: 20654038